Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Supervised Contrastive Representation Learning for Semi-Supervised Time-Series Classification.

IEEE transactions on pattern analysis and machine intelligence·2023
Same author

Output Regularization With Cluster-Based Soft Targets.

IEEE transactions on neural networks and learning systems·2023
Same author

Self-Supervised Learning for Label- Efficient Sleep Stage Classification: A Comprehensive Evaluation.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2023
Same author

TaskDrop: A competitive baseline for continual learning of sentiment classification.

Neural networks : the official journal of the International Neural Network Society·2022
Same author

Self-Supervised Autoregressive Domain Adaptation for Time Series Data.

IEEE transactions on neural networks and learning systems·2022
Same author

Toward Multidiversified Ensemble Clustering of High-Dimensional Data: From Subspaces to Metrics and Beyond.

IEEE transactions on cybernetics·2021

Related Experiment Video

Updated: May 19, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Positive-unlabeled learning for disease gene identification.

Peng Yang1, Xiao-Li Li, Jian-Ping Mei

  • 1Bioinformatics Research Centre, School of Computer Engineering, Nanyang Technological University, Singapore. yang0293@e.ntu.edu.sg

Bioinformatics (Oxford, England)
|August 28, 2012
PubMed
Summary

This study introduces a new machine learning approach, PUDI (PU learning for disease gene identification), to accurately identify disease genes. By treating unknown genes as unlabeled data, PUDI significantly outperforms existing methods in biomedical research.

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: May 19, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

  • Genomics
  • Bioinformatics
  • Machine Learning

Background:

  • Identifying disease genes is crucial but challenging in biomedical research.
  • Current machine learning methods use noisy negative sets, limiting accuracy.
  • This limitation stems from treating unknown genes as definitively non-disease genes.

Purpose of the Study:

  • To develop a more accurate method for disease gene identification.
  • To address the limitations of existing machine learning approaches in handling unknown gene data.
  • To introduce a novel positive-unlabeled (PU) learning algorithm for this task.

Main Methods:

  • Designed a novel PU learning algorithm named PUDI (PU learning for disease gene identification).
  • Treated unknown genes as an unlabeled set (U) instead of a negative set (N).
  • Partitioned U into reliable negative, likely positive, likely negative, and weak negative sets, then used weighted support vector machines for classification.

Main Results:

  • The PUDI algorithm demonstrated superior performance compared to existing methods.
  • Experimental results confirmed the significant improvement in disease gene identification accuracy.
  • The approach effectively handles the ambiguity of unknown gene datasets.

Conclusions:

  • The PUDI algorithm accurately identifies disease genes by appropriately handling unlabeled data.
  • PU learning methods offer a promising avenue for improving machine learning in biomedical research.
  • This approach can be broadly applied to other biomedical problems with positive and unlabeled data.